SID	Source Type	Flags	Enzyme	rerun	SampleID	Control / Cardiotoxicity	Control / Cardiotoxicity [2]	Year of birth	Sex	Length [cm] [N]	Weight [kg] [N]	BMI [kg/mm2] [N]	LVEF (ultrasound) [%] [N]	Cancer type	Chemotherapeutic agents	Virus in biopsy (copies per microgram DNA)	Collagen volume fraction biopsy [%] [N]	Inflammation biopsy	Inflammatory cells biopsy (CD45 + CD68) [n per mm2] [N]	Genetic mutation	Comorbidities	Death?
10188	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	no	20161003_004_10188	Late onset cardiotoxicity	Endomyocardial biopsy chronic cardiotox patients	1963	female	167	82	29	25	Breast cancer	Cyclophosphamide	No	37	No	8	Incomplete (negative)	None	No
686	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	no	20161003_006_686	Control patients	Endomyocardial biopsy control patients	1948	female	170	72	25	20	"""-"""	-	PVB19 (402)	14	No	6	Incomplete (negative)	"Fibromyalgia, Morbus Crohn"	No
534	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	no	20161003_007_534	Control patients	Endomyocardial biopsy control patients	1955	female	169	77	27	39	"""-"""	-	PVB19 (<200)	3	No	13	Incomplete (negative)	Diverticulitis	No
10201	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	no	20161003_009_10201	Late onset cardiotoxicity	Endomyocardial biopsy chronic cardiotox patients	1959	female	170	74	26	23	Breast cancer	"Doxorubicin, cyclophosphamide, everolimus, exemestane, taxotene"	PVB19 (2606)	3	Yes	20	None	None	No
10132	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	no	20161003_010_10132	Late onset cardiotoxicity	Endomyocardial biopsy chronic cardiotox patients	1932	female	166	80	29	34	Breast cancer	"Epirubicin, docetaxel"	PVB19 (406)	59	Yes	14	(MYHA-6 (variant of unknown significance))	Hypertension	No
10130	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	no	20161003_012_10130	Late onset cardiotoxicity	Endomyocardial biopsy chronic cardiotox patients	1958	female	182	95	29	44	Breast cancer	"Doxorubicin, cyclophosphamide, rituximab, vincristin, prednison"	PVB19 (1829)	34	Yes	64	None	None	No
271	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	no	20161003_013_217	Control patients	Endomyocardial biopsy control patients	1944	female	169	73	26	22	"""-"""	-	No	5	Yes	33	None	Chronic kidney disease	Yes
442	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	no	20161003_015_442	Control patients	Endomyocardial biopsy control patients	1941	female	152	69	30	26	"""-"""	- 	PVB19 (<200)	6	No	13	Unknown	Asthma	No
10206	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	no	20161003_016_10206	Late onset cardiotoxicity	Endomyocardial biopsy chronic cardiotox patients	1963	male	173	68	23	65	Chronic lymphatic leukemia	"Doxorubicin, cyclophosphamide, vincristin, prednison"	HHV6 (<200)	4	No	11	Unknown	Kidneyfunction disorder	No
10217	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	no	20161003_019_10217	Late onset cardiotoxicity	Endomyocardial biopsy chronic cardiotox patients	1946	female	169	79	28	35	Adenocarcinoma uterus	"Doxorubicin, cyclophosphamide, 5-fluorouracil (=5-FU)"	"EBV (<200), HHV6 (<200), PVB19 (<200)"	4	No	9	Incomplete (negative)	"Hypertension, Transient ischemic attack"	No
407	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	no	20161003_020_407	Control patients	Endomyocardial biopsy control patients	1964	female	163	73	28	39	"""-"""	-	No	0	No	12	None	None	No
10204	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	no	20161003_022_10204	Late onset cardiotoxicity	Endomyocardial biopsy chronic cardiotox patients	1948	female	153	64	27	15	Breast cancer	"cyclophosphamide, letrozol"	PVB19 (<200)	5	No	12	None	None	No
397	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	no	20161003_023_397	Control patients	Endomyocardial biopsy control patients	1988	male	179	73	23	47	"""-"""	-	PVB19 (330)	18	No	6	None	None	No
523	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	no	20161003_025_523	Control patients	Endomyocardial biopsy control patients	1960	female	153	60	26	20	"""-"""	-	HHV6 (354)	6	Yes	18	None	None	No
10198 (!)	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	no	20161003_026_10198	Late onset cardiotoxicity	Endomyocardial biopsy chronic cardiotox patients	1958	female	174	92	30	31	Breast cancer	Anthracycline + hormonal therapy	PVB19 (<200)	14	No	3	Unknown	None	No
562	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	no	20161003_028_562	Control patients	Endomyocardial biopsy control patients	1964	female	177	92	29	20	"""-"""	-	"EBV (<200), HHV6 (<200)"	7	Yes	17	(DSP-gen (variant of unknown significance))	Fibromyalgia	No
10021	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	yes	20170428_02_heartbiopsy_1	Control patients	Endomyocardial biopsy control patients	1944	female	169	82	29	32	"""-"""	-	PVB19 (2756)	11	No	6	Unknown	Chronic kidney disease	Yes
614	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	yes	20170428_03_heartbiopsy_2	Late onset cardiotoxicity	Endomyocardial biopsy chronic cardiotox patients	1946	female	165	62	23	33	Breast cancer	"Doxorubicin, cyclophosphamide, 5-fluorouracil (=5-FU)"	PVB19 (<200)	18	No	7	SCN5A (pathogenic)	None	No
10059	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	yes	20170428_05_heartbiopsy_4	Control patients	Endomyocardial biopsy control patients	1973	female	168	64	23	19	"""-"""	-	PVB19 (<200)	6	No	10	Unknown	"Hypertension, Acute Kidney disease"	No
10027	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	yes	20170428_06_heartbiopsy_5	Late onset cardiotoxicity	Endomyocardial biopsy chronic cardiotox patients	1949	female	170	86	30	20	Breast cancer	"Doxorubicin, epirubicin, tamoxifen"	PVB19 (492)	17	Yes	26	(TTN (variant of unknown significance))	None	Yes
10033	Thermo	Aligned|BG Subtracted|Clamped	Trypsin	yes	20170428_11_heartbiopsy_3	Control patients	Endomyocardial biopsy control patients	1948	male	174	106	35	20	Prostate cancer	#NAME?	PVB19 (<200)	11	No	8	(RBM20 and TMEM43 (variants of unknown significance))	None (prostate cancer)	No
